BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26427666)

  • 1. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
    Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
    Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
    Oliveira C; Rinck-Junior JA; Lourenço GJ; Moraes AM; Lima CS
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1199-206. PubMed ID: 23568549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; de Moraes AM; Lima CS
    Med Oncol; 2017 Feb; 34(2):19. PubMed ID: 28050764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
    Carron J; Brito AB; Torelli AC; Oliveira C; Derchain SF; Lima CS; Lourenço GJ
    Med Oncol; 2016 Oct; 33(10):112. PubMed ID: 27586145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
    Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
    Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
    Zhao R; Chen G
    Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
    Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms in nucleotide excision repair pathway genes with susceptibility to cutaneous melanoma.
    Hashemzehi A; Ghadyani M; Asadian F; Dastgheib SA; Kargar S; Neamatzadeh H; Akbarian E; Emarati A
    Klin Onkol; 2021; 34(5):350-355. PubMed ID: 34702042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.
    Cotignola J; Chou JF; Roy P; Mitra N; Busam K; Halpern AC; Orlow I
    J Invest Dermatol; 2012 May; 132(5):1471-8. PubMed ID: 22336942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
    J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
    Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
    J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between polymorphisms in genes related to DNA base-excision repair with risk and prognosis of oropharyngeal squamous cell carcinoma.
    Costa EF; Santos ES; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Mariano FV; Coutinho-Camillo CM; Altemani A; Lima CS; Lourenço GJ
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1917-26. PubMed ID: 27372710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.
    Ibarrola-Villava M; Martin-Gonzalez M; Lazaro P; Pizarro A; Lluch A; Ribas G
    Br J Dermatol; 2012 Jun; 166(6):1176-83. PubMed ID: 22251241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
    Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
    Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.